1. Home
  2. VSCO vs ANIP Comparison

VSCO vs ANIP Comparison

Compare VSCO & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSCO
  • ANIP
  • Stock Information
  • Founded
  • VSCO 1977
  • ANIP 2001
  • Country
  • VSCO United States
  • ANIP United States
  • Employees
  • VSCO N/A
  • ANIP N/A
  • Industry
  • VSCO Clothing/Shoe/Accessory Stores
  • ANIP Biotechnology: Pharmaceutical Preparations
  • Sector
  • VSCO Consumer Discretionary
  • ANIP Health Care
  • Exchange
  • VSCO Nasdaq
  • ANIP Nasdaq
  • Market Cap
  • VSCO 1.6B
  • ANIP 1.4B
  • IPO Year
  • VSCO N/A
  • ANIP N/A
  • Fundamental
  • Price
  • VSCO $18.70
  • ANIP $63.93
  • Analyst Decision
  • VSCO Hold
  • ANIP Strong Buy
  • Analyst Count
  • VSCO 12
  • ANIP 9
  • Target Price
  • VSCO $26.33
  • ANIP $80.56
  • AVG Volume (30 Days)
  • VSCO 3.0M
  • ANIP 319.2K
  • Earning Date
  • VSCO 08-27-2025
  • ANIP 08-08-2025
  • Dividend Yield
  • VSCO N/A
  • ANIP N/A
  • EPS Growth
  • VSCO 55.42
  • ANIP N/A
  • EPS
  • VSCO 2.07
  • ANIP N/A
  • Revenue
  • VSCO $6,224,000,000.00
  • ANIP $674,068,000.00
  • Revenue This Year
  • VSCO $2.09
  • ANIP $31.40
  • Revenue Next Year
  • VSCO $1.82
  • ANIP $7.38
  • P/E Ratio
  • VSCO $9.03
  • ANIP N/A
  • Revenue Growth
  • VSCO 1.47
  • ANIP 30.27
  • 52 Week Low
  • VSCO $13.76
  • ANIP $52.50
  • 52 Week High
  • VSCO $48.73
  • ANIP $77.00
  • Technical
  • Relative Strength Index (RSI)
  • VSCO 42.95
  • ANIP 44.83
  • Support Level
  • VSCO $17.53
  • ANIP $62.61
  • Resistance Level
  • VSCO $21.75
  • ANIP $68.18
  • Average True Range (ATR)
  • VSCO 0.99
  • ANIP 2.38
  • MACD
  • VSCO -0.10
  • ANIP -0.40
  • Stochastic Oscillator
  • VSCO 25.05
  • ANIP 22.04

About VSCO Victorias Secret & Co.

Victoria's Secret & Co is a retailer of women's intimate and other apparel and beauty products marketed under the Victoria's Secret, PINK, and Adore Me brand names. It also includes the merchandise sourcing and production function serving the Company and its international partners. The Company operates as a single segment designed to serve customers seamlessly through stores and online channels.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Share on Social Networks: